chlorambucil has been researched along with Hemorrhagic Thrombocythemia in 7 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In polycythemia vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%." | 7.69 | Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. ( Fisher, SG; Godwin, J; Nand, S; Stock, W, 1996) |
| " Randomized studies have shown that the risk of thrombosis was significantly reduced in ET with the use of hydroxyurea (HU) and in PV with the use of chlorambucil or 32P." | 4.80 | Treatment of polycythaemia vera and essential thrombocythaemia. ( Silverstein, MN; Tefferi, A, 1998) |
| "In polycythemia vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%." | 3.69 | Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. ( Fisher, SG; Godwin, J; Nand, S; Stock, W, 1996) |
| "The authors report the case of a man suffering from rheumatoid arthritis treated for almost 5 years with chlorambucil." | 3.65 | [Acute leukemia with megakaryoblasts. Incidence following immunosuppressive treatment of rheumatoid polyarthritis]. ( Delbarre, F; Delrieu, F; Lévy, JP; Mathiot, C; Menkès, CJ; Weill, B, 1975) |
| "Its use in the treatment of essential thrombocythemia began later in 1950." | 2.41 | Treatment of the myeloproliferative disorders with 32P. ( Berlin, NI, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Case, DC | 1 |
| Nand, S | 1 |
| Stock, W | 1 |
| Godwin, J | 1 |
| Fisher, SG | 1 |
| Tefferi, A | 1 |
| Silverstein, MN | 2 |
| Berlin, NI | 1 |
| Menkès, CJ | 1 |
| Lévy, JP | 1 |
| Weill, B | 1 |
| Delrieu, F | 1 |
| Mathiot, C | 1 |
| Delbarre, F | 1 |
| McNutt, DR | 1 |
| Fudenberg, HH | 1 |
2 reviews available for chlorambucil and Hemorrhagic Thrombocythemia
| Article | Year |
|---|---|
Treatment of polycythaemia vera and essential thrombocythaemia.
Topics: Adult; Aged; Aspirin; Chlorambucil; Disease Progression; Female; Hemorrhage; Humans; Hydroxyurea; In | 1998 |
Treatment of the myeloproliferative disorders with 32P.
Topics: Adult; Aged; Alkylating Agents; Chlorambucil; Clinical Trials as Topic; Combined Modality Therapy; D | 2000 |
5 other studies available for chlorambucil and Hemorrhagic Thrombocythemia
| Article | Year |
|---|---|
Therapy of essential thrombocythemia with thiotepa and chlorambucil.
Topics: Adult; Aged; Bone Marrow; Chlorambucil; Dose-Response Relationship, Drug; Female; Hematocrit; Humans | 1984 |
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Topics: Acute Disease; Anemia, Refractory, with Excess of Blasts; Busulfan; Cell Transformation, Neoplastic; | 1996 |
Myeloproliferative diseases.
Topics: Adult; Aged; Chlorambucil; Female; Humans; Male; Melphalan; Middle Aged; Myeloproliferative Disorder | 1977 |
[Acute leukemia with megakaryoblasts. Incidence following immunosuppressive treatment of rheumatoid polyarthritis].
Topics: Arthritis, Rheumatoid; Blood Cell Count; Bone Marrow Cells; Chlorambucil; Humans; Immunosuppressive | 1975 |
Disseminated scotochromogen infection and unusual myeloproliferative disorder. Report of a case and review of the literature.
Topics: Adolescent; Adult; Aged; Autopsy; Busulfan; Child; Child, Preschool; Chlorambucil; Female; Humans; L | 1971 |